Our lab received one of the 17 pilot grants awarded by the University of Pittsburgh Clinical and Translational Science Institute (CTSI) on basic SARS-CoV-2 research. SARS-CoV-2 is the coronavirus that causes COVID-19, currently a pandemic affecting people around the globe.
Dr. Doug Fischer will be leading the project to understand how the virus replicates in cells, including live-cell imaging at the Center for Biologic Imaging. Understanding how SARS-CoV-2 infects different cell types will help development of therapeutics for COVID-19.
We are grateful to be a part of Pitt's Center for Vaccine Research (CVR) and to work with our colleagues in the Regional Biocontainment Laboratory who have been performing SARS-CoV-2 research since February.
Stay tuned for more information!
Recent Comments